These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6330065)

  • 21. Growth and maturation of a vesicular stomatitis virus temperature-sensitive mutant and its central nervous system isolate.
    Hughes JV; Johnson TC; Rabinowitz SG; Dal Canto MC
    J Virol; 1979 Jan; 29(1):312-21. PubMed ID: 219225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the oligosaccharide structure of the glycoprotein of vesicular stomatitis virus and a thermolabile mutant (tl-17).
    Robertson JS; Etchison JR; Summers DF
    J Gen Virol; 1982 Jan; 58 Pt 1():13-23. PubMed ID: 6292339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleiotropic resistance to glycoprotein processing inhibitors in Chinese hamster ovary cells. The role of a novel mutation in the asparagine-linked glycosylation pathway.
    Lehrman MA; Zeng Y
    J Biol Chem; 1989 Jan; 264(3):1584-93. PubMed ID: 2521484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of yeast exoglucanases by glucosidase inhibitors.
    Ridruejo JC; Muñoz MD; Andaluz E; Larriba G
    Biochim Biophys Acta; 1989 Dec; 993(2-3):179-85. PubMed ID: 2532041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of castanospermine on the oligosaccharide structures of glycoproteins from lymphoma cell lines.
    Palamarczyk G; Elbein AD
    Biochem J; 1985 May; 227(3):795-804. PubMed ID: 3924028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-methyl-1-deoxynojirimycin, a novel inhibitor of glycoprotein processing, and its effect on fowl plague virus maturation.
    Romero PA; Datema R; Schwarz RT
    Virology; 1983 Oct; 130(1):238-42. PubMed ID: 6636538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions.
    Whitt MA; Rose JK
    Virology; 1991 Dec; 185(2):875-8. PubMed ID: 1660205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.
    Whitt MA; Zagouras P; Crise B; Rose JK
    J Virol; 1990 Oct; 64(10):4907-13. PubMed ID: 2168975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of vesicular stomatitis virus infection by spike glycoprotein. Evidence for an intracellular, G protein-requiring step.
    Miller DK; Lenard J
    J Cell Biol; 1980 Feb; 84(2):430-7. PubMed ID: 6247355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of carbohydrate trimming for the antigenicity of the Semliki Forest virus glycoprotein E2.
    Kaluza G; Repges S; McDowell W
    Virology; 1990 Jun; 176(2):369-78. PubMed ID: 1693245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of recombinant endomannosidase for evaluation of the processing of N-linked oligosaccharides of glycoproteins and their oligosaccharide-lipid precursors.
    Spiro MJ; Spiro RG
    Glycobiology; 2000 May; 10(5):521-9. PubMed ID: 10764841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of deoxymannojirimycin on the processing of the influenza viral glycoproteins.
    Elbein AD; Legler G; Tlusty A; McDowell W; Schwarz R
    Arch Biochem Biophys; 1984 Dec; 235(2):579-88. PubMed ID: 6240228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in the structure of the oligosaccharide of vesicular stomatitis virus G protein by swainsonine.
    Kang MS; Elbein AD
    J Virol; 1983 Apr; 46(1):60-9. PubMed ID: 6298470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Castanospermine and other plant alkaloid inhibitors of glucosidase activity block the growth of HIV.
    Tyms AS; Berrie EM; Ryder TA; Nash RJ; Hegarty MP; Taylor DL; Mobberley MA; Davis JM; Bell EA; Jeffries DJ
    Lancet; 1987 Oct; 2(8566):1025-6. PubMed ID: 2889932
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing.
    Sunkara PS; Bowlin TL; Liu PS; Sjoerdsma A
    Biochem Biophys Res Commun; 1987 Oct; 148(1):206-10. PubMed ID: 2960321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus.
    Metsikkö K; Garoff H
    J Virol; 1989 Dec; 63(12):5111-8. PubMed ID: 2555547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newly synthesized G protein of vesicular stomatitis virus is not transported to the Golgi complex in mitotic cells.
    Featherstone C; Griffiths G; Warren G
    J Cell Biol; 1985 Dec; 101(6):2036-46. PubMed ID: 2999158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective retention of monoglucosylated high mannose oligosaccharides by a class of mutant vesicular stomatitis virus G proteins.
    Suh K; Bergmann JE; Gabel CA
    J Cell Biol; 1989 Mar; 108(3):811-9. PubMed ID: 2537836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the role of glycans for the biological activity of Semliki Forest virus grown in Aedes albopictus cells using inhibitors of asparagine-linked oligosaccharides trimming.
    Naim HY; Koblet H
    Arch Virol; 1988; 102(1-2):73-89. PubMed ID: 2973779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and infectivity of vesicular stomatitis virus containing nonglycosylated G protein.
    Gibson R; Leavitt R; Kornfeld S; Schlesinger S
    Cell; 1978 Apr; 13(4):671-9. PubMed ID: 207437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.